How has your [Global Demographic Tailwind] portfolio done against the S&P this year?
Several of the stocks I’ve cited as beneficiaries of The Global Demographic Tailwind are trading at or near multi-year or all-time highs. In the drug/biotech arena, PFE is an example of the former, and PKI, AGN, and ABT are examples of the latter.